BiotechTube
Home/PolyPid/Ori Warshavsky
OW

Ori Warshavsky

Chief Operating Officer – US

PolyPid

Therapeutic Areas

Surgical CareMetabolic DiseaseOncology

PolyPid Pipeline

DrugIndicationPhase
D-PLEX 100Prevention of surgical site infections after abdominal colorectal surgeryRegulatory Review
PP03AMetabolic disease – ultra‑long‑acting GLP‑1 receptor agonistPreclinical
PP04AOncology – intratumoral STING agonistPreclinical

Leadership Team at PolyPid

DC
Dikla Czaczkes
Chief Executive Officer
DF
Dalit Fellous Hazan
Deputy CEO, EVP R&D, Clinical and Regulatory Affairs
View full PolyPid profile